Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 37, 2007 - Issue 1
92
Views
14
CrossRef citations to date
0
Altmetric
Original

Prediction of pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in humans using animal data

, , , &
Pages 91-102 | Received 18 Aug 2006, Accepted 19 Sep 2006, Published online: 12 Jul 2010

References

  • Adolph EF. Quantitative relations in the physiological constitutions of mammals. Science 1949; 109: 579–585
  • Boxenbaum H, Ronfeld R. Interspecies pharmacokinetic scaling and the Dedrick plots. American Journal of Physiology 1983; 245: R768–R775
  • Chow HH. A physiologically based pharmacokinetic model of zidovudine (AZT) in the mouse: Model development and scale-up to humans. Journal of Pharmaceutical Sciences 1997; 86: 1223–1228
  • Craig WA. The pharmacology of meropenem, a new carbapenem antibiotic. Clinical Infectious Diseases 1997; 24(Suppl. 2)S266–S275
  • Craig WA. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 1998; 26: 1–10
  • Dedrick RL. Animal scale-up. Journal of Pharmacokinetics and Biopharmaceutics 1973; 1: 435–461
  • Drusano GL. Prevention of resistance: A goal for dose selection for antimicrobial agents. Clinical Infectious Diseases 2003; 36(Suppl. 1)S42–S50
  • Efthymiopoulos C, Battaglia R, Benedetti MS. Animal pharmacokinetics and interspecies scaling of FCE 22101, a penem antibiotic. Journal of Antimicrobial Chemotherapy 1991; 27: 517–526
  • Kawai R, Mathew D, Tanaka C, Rowland M. Physiologically based pharmacokinetics of cyclosporine A: Extension to tissue distribution kinetics in rats and scale-up to human. Journal of Pharmacology and Experimental Therapeutics 1998; 287: 457–468
  • Kawamoto I, Shimoji Y, Kanno O, Kojima K, Ishikawa K, Matsuyama E, Ashida Y, Shibayama T, Fukuoka T, Ohya S. Synthesis and structure–activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety. Journal of Antibiotics 2003; 56: 565–579
  • Khor SP, Amyx H, Davis ST, Nelson D, Baccanari DP, Spector T. Dihydropyrimidine dehydrogenase inactivation and 5-fluorouracil pharmacokinetics: Allometric scaling of animal data, pharmacokinetics and toxicokinetics of 5-fluorouracil in humans. Cancer Chemotherapy and Pharmacology 1997; 39: 233–238
  • Kim SH, Kim WB, Lee MG. Interspecies pharmacokinetic scaling of a new carbapenem, DA-1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics. Biopharmaceutics and Drug Disposition 1998; 19: 231–235
  • Koga T, Abe T, Inoue H, Takenouchi T, Kitayama A, Yoshida T, Masuda N, Sugihara C, Kakuta M, Nakagawa M, Shibayama T, Matsushita Y, Hirota T, Ohya S, Utsui Y, Fukuoka T, Kuwahara S. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem. Antimicrobial Agents and Chemotherapy 2005; 49: 3239–3250
  • Kurihara A, Naganuma H, Hisaoka M, Tokiwa H, Kawahara Y. Prediction of human pharmacokinetics of panipenem-betamipron, a new carbapenem, from animal data. Antimicrobial Agents and Chemotherapy 1992; 36: 1810–1816
  • Matsushita H, Suzuki H, Sugiyama Y, Sawada Y, Iga T, Hanano M, Kawaguchi Y. Prediction of the pharmacokinetics of cefodizime and cefotetan in humans from pharmacokinetic parameters in animals. Journal of Pharmacobio-Dynamics 1990; 13: 602–611
  • Mehta SC, Lu DR. Interspecies pharmacokinetic scaling of BSH in mice, rats, rabbits, and humans. Biopharmaceutics and Drug Disposition 1995; 16: 735–744
  • Mitsuhashi Y, Sugiyama Y, Ozawa S, Nitanai T, Sasahara K, Nakamura K, Tanaka M, Nishimura T, Inaba M, Kobayashi T. Prediction of ACNU plasma concentration–time profiles in humans by animal scale-up. Cancer Chemotherapy and Pharmacology 1990; 27: 20–26
  • Pacifici GM, Viani A. Methods of determining plasma and tissue binding of drugs. Pharmacokinetics consequences. Clinical Pharmacokinetics 1992; 23: 449–468
  • Rennecke JT, Hirota T, Shibayama T, Matsushita Y, Kuwahara S, Puchler K, Ruhland A, Drewelow B (2002) Safety, tolerability, and pharmacokinetics (PK) of CS-023, a new parenteral carbapenem, in healthy male volunteers. Paper presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy;, San Diego, CAUSA, 27–30 September, 2002. American Society for Microbiology, Washington, DC, F-327
  • Richter WF, Heizmann P, Meyer J, Starke V, Lave T. Animal pharmacokinetics and interspecies scaling of Ro 25-6833 and related (lactamylvinyl)cephalosporins. Journal of Pharmaceutical Sciences 1998; 87: 496–500
  • Sawada Y, Hanano M, Sugiyama Y, Iga T. Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals. Journal of Pharmacokinetics and Biopharmaceutics 1984; 12: 241–261
  • Shibayama T, Matsushita Y, Kikuchi N, Kawai K, Hirota T, Kuwahara S (2000) R-115685, a novel parenteral Carbapenem: Pharmacokinetics and metabolism in laboratory animals. Paper presented at the 40th Interscience Conference on Antibacterial Agents and Chemotherapy, Toronto, Ont.Canada, 17–20 September, 2000. American Society for Microbiology, Washington, DC, F-1233
  • Takahagi H, Hirota H, Matsushita Y, Muramatsu M, Tanaka M, Matsuo E. In vitro dehydropeptidase-I activity and its hydrolytic activity of panipenem in several tissues in animal species and their influence on the disposition of panipenem in vivo. Chemotherapy (Tokyo) 1991; 39(Suppl. 3)236–241
  • Thomson KS, Moland ES. CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 2004; 54: 557–562
  • Tsuji A, Sato H, Tamai I, Adachi H, Nishihara T, Ishiguro M, Ohnuma N, Noguchi T. Physiologically based pharmacokinetics of a new penem, SUN5555, for evaluation of in vivo efficacy. Drug Metabolism and Disposition 1990; 18: 245–252

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.